3189 results for «3545»

Filter By

3189 results

SELUTION DeNovo study: powered to change medical practice

18 May 2021 – From EuroPCR 2021

Watch this session presented by Christian Spaulding in order to gain insight into how the SELUTION DeNovo study could change medical practice, to understand the strategy and what differentiates the SELUTION DeNovo study, and to learn about the study design and key milestones.

SELUTION DeNovo study: powered to change medical practice

EuroIntervention - Most cited papers of the year 2020

18 May 2021 – From EuroPCR 2021

Thanks to this session, which was originally presented during EuroPCR 2021, by D. Capodanno, Editor-in-chief, and N. Gonzalo & D. Mylotte, deputy editors, discover the top 3 most cited EuroIntervention Journal papers in 2020, and hear the reaction of the winner, interviewed for the occasion.

EuroIntervention - Most cited papers of the year 2020

EuroPCR 2021 - Innovations in peripheral and structural interventions

18 May 2021 – From EuroPCR 2021

In this session, discover how an effective calcium debridement procedure in stenotic aortic valves may restore the valve function, and why biometric indicators and engineering characteristics are so important for effective and safe delivery of endovascular care.

EuroPCR 2021 - Innovations in peripheral and structural interventions

Revascularisation for chronic coronary syndrome and multivessel disease (Part 1) - Session with LIVE demonstration

18 May 2021 – From EuroPCR 2021

Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation, to appraise how to select the optimal revascularisation strategy in such patients and to learn how to perform state-of-the-art PCI to achieve optimal procedural outcomes.

This session was originally presented...

Revascularisation for chronic coronary syndrome and multivessel disease - Part 1

Revascularisation for chronic coronary syndrome and multivessel disease - Part 2

18 May 2021 – From EuroPCR 2021

Watch this session if you want to  understand when patients with CCS and MVD should undergo revascularisation and to appraise how to select the optimal revascularisation strategy in such patients.

This session was originally presented during EuroPCR 2021.

Revascularisation for chronic coronary syndrome and multivessel disease - Part 2

Multivessel disease revascularisation: balancing the risk

19 May 2021 – From EuroPCR 2021

Watch this session presented by Jean Fajadet, Thomas Cuisset, Bruno Farah, Marek Grygier, Maciej Lesiak and Sylwia Iwanczyk in order to understand the selection of PCI for multivessel disease patients, to demonstrate the best treatment strategy for patients presenting with multivessel disease, and to discuss DAPT strategy in multivessel...

Multivessel disease revascularisation: balancing the risk

Challenges and opportunities in high-risk patients undergoing TAVI

19 May 2021 – From EuroPCR 2021

Watch this session presented by Marco Valgimigli, Raul Moreno and Peter Nordbeck in order to discuss the designing TAVI trial for high-risk patients, the timing of TAVI and PCI, as well as the balance between thrombosis prevention and bleeding mitigation

Challenges and opportunities in high-risk patients undergoing TAVI

EuroPCR 2021 Hotlines / Late-Breaking Trials: Alster-FLX, ANGIE, COLOR, CREDENCE BRS, and P3

27 May 2021 – From EuroPCR 2021

Find out more about various studies & registries:

  • Left atrial appendage occlusion with the WATCHMAN FLX: The Alster-FLX Registry
  • Anatomical snuffbox for coronary angiography and interventions
  • Randomized comparison between Radial and Femoral Large-bore access Complex PCI
  • Experience with BRS for treatment of de novo native peripheral artery lesions
  • Clinical validation of...
EuroPCR 2021 Hotlines / Late-Breaking Trials: Alster-FLX, ANGIE, COLOR, CREDENCE BRS, and P3

The future and vision of intravascular imaging

18 May 2021 – From EuroPCR 2021

Watch this session presented by Nieves Gonzalo in order to highlight the benefits and future of intravascular imaging, to share the benefits of using a structured and streamlined workflow, MLD-MAX, and to understand the benefits of using AI during the crucial steps of PCI.

The future and vision of intravascular imaging

The future of PCI seems bright - The MagicTouch sirolimus-coated balloon

18 May 2021 – From EuroPCR 2021

Watch this session presented by Antonio Colombo, Bernardo Cortese and Sandeep Basavarajaiah in order to understand the strategy behind using a DCB as a proper solution for CAD and the result and potential of using a Sirolimus DCB in coronary intervention, as well as to get insights into real...

The future of PCI seems bright - The MagicTouch sirolimus-coated balloon

Tricuspid interventions

27 Nov 2022 – From PCR London Valves 2022

How to manage tricuspid valve disease in a patient with atrial fibrillation, transcatheter tricuspid valve repair with transthoracic echocardiography guidance, or a patient with severe tricuspid regurgitation with a novel transcatheter treatment? Watch this PCR LV 2022 session for answers!

Tricuspid interventions

Rapid-fire clinical cases: session 2

27 Nov 2022 – From PCR London Valves 2022

Discover in the same PCR LV 2022 session a TAVI for pure aortic regurgitation in degenerated aortic homograft, an embolised Myval transcatheter heart valve to AAA, or a challenging ViV TAVI, and much more!

Rapid-fire clinical cases: session 2

Ensuring optimal TAVI outcomes - LIVE case

27 Nov 2022 – From PCR London Valves 2022

A 75-year-old female with diabetes and history of ischemic stroke 5 years ago presents a symptomatic severe aortic valve stenosis in a small annulus.
After pre-dilatation (18 mm balloon), the operators implant an Acurate neo2 23 mm with a sentinel cerebral embolic protection device. Watch them perform...

Ensuring optimal TAVI outcomes

Hot TAVI topics - Emerging indications

27 Nov 2022 – From PCR London Valves 2022

Consult this session on hot TAVI topics to learn more about the under-treatment problem of patients with aortic valve disease, the rationale behind emerging TAVI indications and ongoing trials, as well as the nuances of patient selection and the key role of cardiac imaging in identifying markers of...

Hot TAVI topics - Emerging indications

TAVI: vascular access and bleeding complications

27 Nov 2022 – From PCR London Valves 2022

To learn more about FAST ACCESS Pilot, transfemoral-only TAVI, next-generation suture-mediated closure device in TAVR, or percutaneous axillary TAVI under local anaesthesia, among others, watch this session from PCR LV 2022!

TAVI: vascular access and bleeding complications

Primary mitral regurgitation: treatment options when the anatomy is complex

27 Nov 2022 – From PCR London Valves 2022

Take a look at these presentations to learn more about complex primary mitral regurgitation (and how to differentiate it from simple disease), to understand why it is complex and to know what the treatment options are.

Primary mitral regurgitation: treatment options when the anatomy is complex

Paravalvular leak closure

27 Nov 2022 – From PCR London Valves 2022

5 specific cases are proposed in this PCR LV 2022 session dedicated to PVL, including concomitant ViV TAVI and paravalvular leak closure, transapical mitral paravalvular leak closure in a young patient, or transcatheter mitral ViV implantation for paravalvular leak. Watch the videos now to find out more!

Paravalvular leak closure

Repair vs. replacement for the treatment of tricuspid valve disease

27 Nov 2022 – From PCR London Valves 2022

Watch this session on tricuspid valve disease to learn more about its current modes of treatment (including new and emerging devices), to understand which patients are the best candidates for this procedure and to explore the challenges that may be encountered during it.

Repair vs. replacement for the treatment of tricuspid valve disease

Tricuspid and pulmonary interventions

27 Nov 2022 – From PCR London Valves 2022

Watch this series of cases presented at PCR LV 2022 and learn more about Alagille syndrome, how to treat a significant right-to-left shunt after bicaval valve implantation, or analyze transcatheter pulmonary valve implantation in tetralogy of Fallot, among others.

Tricuspid and pulmonary interventions

TAVI: emerging evidence

27 Nov 2022 – From PCR London Valves 2022

Through the 5 abstracts of this PCR LV 2022 session, follow the comparison between last-generation balloon and self-expandable TAVR for bicuspid aortic valve stenosis, and the comparison between multiple tools to assess the risk of mortality after TAVR, evaluate the impact of post-TAVI vascular complications, and...

TAVI: emerging evidence
Didn’t find what you were looking for?